Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

INAB

IN8bio (INAB)

IN8bio Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:INAB
일자시간출처헤드라인심볼기업
2024/05/1423:00GlobeNewswire Inc.IN8bio Announces Upcoming Presentation at 2024 European Hematology Association CongressNASDAQ:INABIN8bio Inc
2024/05/1321:00GlobeNewswire Inc.IN8bio Demonstrates Robust and Reproducible Gamma-Delta T Cell Therapy Manufacturing in Oral Presentation at ASGCT 2024NASDAQ:INABIN8bio Inc
2024/05/1005:06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:INABIN8bio Inc
2024/05/1005:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INABIN8bio Inc
2024/05/1005:00GlobeNewswire Inc.IN8bio Reports First Quarter 2024 Financial Results and Recent Corporate HighlightsNASDAQ:INABIN8bio Inc
2024/05/0805:05Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:INABIN8bio Inc
2024/04/3019:05GlobeNewswire Inc.IN8bio Doses First Patient in Phase 2 Clinical Trial of INB-400 in Newly Diagnosed GlioblastomaNASDAQ:INABIN8bio Inc
2024/04/2421:00GlobeNewswire Inc.IN8bio Announces Oral Presentation at the Upcoming American Society of Gene & Cell Therapy (ASGCT) 2024 Annual MeetingNASDAQ:INABIN8bio Inc
2024/04/1705:05GlobeNewswire Inc.IN8bio to Present at Noble Capital Markets Emerging Growth Virtual Healthcare Equity ConferenceNASDAQ:INABIN8bio Inc
2024/04/1005:30GlobeNewswire Inc.IN8bio Announces New Preclinical Data for Gamma-Delta nsCAR-T Cell Therapy Platform at AACR 2024NASDAQ:INABIN8bio Inc
2024/03/1505:00GlobeNewswire Inc.IN8bio Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Business HighlightsNASDAQ:INABIN8bio Inc
2024/03/0606:30GlobeNewswire Inc.IN8bio to Present New Preclinical Data on Novel Gamma-Delta CAR Platform Candidate at AACR Annual Meeting 2024NASDAQ:INABIN8bio Inc
2024/02/2622:00Business WireIN8bio to Present at Upcoming Investor ConferencesNASDAQ:INABIN8bio Inc
2024/02/1422:00GlobeNewswire Inc.IN8bio Announces Publication on Novel Gamma-Delta T Cell Therapy for Glioblastoma in Frontiers in ImmunologyNASDAQ:INABIN8bio Inc
2024/02/0906:54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INABIN8bio Inc
2024/02/0906:52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INABIN8bio Inc
2024/02/0906:50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INABIN8bio Inc
2024/02/0906:49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INABIN8bio Inc
2024/02/0906:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INABIN8bio Inc
2024/02/0906:46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INABIN8bio Inc
2024/01/2006:06Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:INABIN8bio Inc
2024/01/1914:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:INABIN8bio Inc
2024/01/1906:31Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:INABIN8bio Inc
2024/01/1307:16Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:INABIN8bio Inc
2024/01/0422:00GlobeNewswire Inc.IN8bio Highlights Recent Company Accomplishments and Outlines 2024 Pipeline GoalsNASDAQ:INABIN8bio Inc
2023/12/2902:28Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:INABIN8bio Inc
2023/12/1606:31Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:INABIN8bio Inc
2023/12/1522:27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INABIN8bio Inc
2023/12/1522:26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INABIN8bio Inc
2023/12/1522:24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INABIN8bio Inc
 검색 관련기사 보기:NASDAQ:INAB